PE2/PE3 mRNA (Cap1, m1Ψ)
| RP-A00044 | |
|
|
|
|
|
|
| Ask us a question | |
| RP-A00044 | |
|
|
|
|
|
|
| Ask us a question | |
Prime editing (PE) systems minimally consist of two components: a programmable DNA nickase fused to an engineered reverse transcriptase and a pegRNA. The PE2/PE3 mRNA sequence was from publication: Nelson, et al. Nat Biotechnology, 2022; 40: 402-410.
|
| Form | Liquid |
| Concentration | 1mg/mL |
| Full mRNA length | 6652nt |
| Full mRNA Molecular Weight | 2167186 |
| Storage buffer | 1mM Sodium citrate, pH6.5 |
| Storage condition | Store at -20°C for short term (<3 months), store at -80°C for long term. |
| Appearance | Clear and free of foreign particles |
| RNA Length | Expected size band detected |
| RNA Content | Target ± 5% |
| Integrity | ≥ 75% |
| OD260/OD280 | 1.70 ~ 2.30 |
| Capping Efficiency | ≥ 90% |
| Endotoxin | < 10 EU/mg |
| pH | Target ± 0.5 |
| Transfect a total of 2 µg of PE2/PE3 mRNA and pegRNA per well, using a transfection reagent, electroporation, or LNP encapsulation in a 24-well plate (~2 × 10⁵ cells/well). Assess genome editing efficiency 48-72 hours post-transfection via sequencing. |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.